- Home
- ARE vs RDY Comparison
ARE vs RDY Comparison
Compare ARE & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARE
- RDY
- Stock Information
- Founded
- ARE 1994
- RDY 1984
- Country
- ARE United States
- RDY India
- Employees
- ARE N/A
- RDY N/A
- Industry
- ARE Real Estate Investment Trusts
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- ARE Real Estate
- RDY Health Care
- Exchange
- ARE Nasdaq
- RDY Nasdaq
- Market Cap
- ARE 13.2B
- RDY 11.6B
- IPO Year
- ARE 1997
- RDY N/A
- Fundamental
- Price
- ARE $83.82
- RDY $14.18
- Analyst Decision
- ARE Buy
- RDY Strong Buy
- Analyst Count
- ARE 8
- RDY 2
- Target Price
- ARE $105.63
- RDY $16.95
- AVG Volume (30 Days)
- ARE 1.4M
- RDY 942.8K
- Earning Date
- ARE 10-27-2025
- RDY 11-04-2025
- Dividend Yield
- ARE 6.30%
- RDY 0.50%
- EPS Growth
- ARE N/A
- RDY 2.20
- EPS
- ARE N/A
- RDY 0.79
- Revenue
- ARE $3,097,996,000.00
- RDY $3,897,394,052.00
- Revenue This Year
- ARE N/A
- RDY $7.33
- Revenue Next Year
- ARE $0.03
- RDY $1.96
- P/E Ratio
- ARE N/A
- RDY $17.68
- Revenue Growth
- ARE 3.00
- RDY 15.86
- 52 Week Low
- ARE $67.37
- RDY $12.26
- 52 Week High
- ARE $123.10
- RDY $16.17
- Technical
- Relative Strength Index (RSI)
- ARE 51.51
- RDY 44.97
- Support Level
- ARE $81.47
- RDY $13.97
- Resistance Level
- ARE $87.54
- RDY $14.22
- Average True Range (ATR)
- ARE 1.80
- RDY 0.19
- MACD
- ARE -0.52
- RDY -0.06
- Stochastic Oscillator
- ARE 34.71
- RDY 27.46
About ARE Alexandria Real Estate Equities Inc.
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.